Furthermore, inhibition of insulin secretion during STZ-induced chronic pancreatic inflammation may be associated with attenuated expression of SPARC and thus mediated dysregulation of β-cell function in the diabetic pancreas. The gene discussed is SPARC; the disease is inflammatory response.